Regeneron Pharmaceuticals' Interest Expenses rose 1619.05% to $12.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $43.8 million, marking a year-over-year decrease of 2065.22%. This contributed to the annual value of $43.8 million for FY2025, which is 2065.22% down from last year.
Per Regeneron Pharmaceuticals' latest filing, its Interest Expenses stood at $12.2 million for Q4 2025, which was up 1619.05% from $19.3 million recorded in Q3 2025.
Regeneron Pharmaceuticals' 5-year Interest Expenses high stood at $19.3 million for Q3 2025, and its period low was $3.6 million during Q2 2025.
In the last 5 years, Regeneron Pharmaceuticals' Interest Expenses had a median value of $14.5 million in 2021 and averaged $14.4 million.
In the last 5 years, Regeneron Pharmaceuticals' Interest Expenses surged by 13934.43% in 2021 and then tumbled by 7567.57% in 2025.
Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Interest Expenses stood at $14.1 million in 2021, then rose by 23.4% to $17.4 million in 2022, then rose by 5.17% to $18.3 million in 2023, then crashed by 42.62% to $10.5 million in 2024, then increased by 16.19% to $12.2 million in 2025.
Its Interest Expenses stands at $12.2 million for Q4 2025, versus $19.3 million for Q3 2025 and $3.6 million for Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value